drugset / Trial / NCT00685958

Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

NCT00685958

Phase 3 Completed 54 enrolled Sanofi
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of enoxaparin on bleeding and venous blood clots in patients with hip fracture surgery.

Timeline

Start
2006-07
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified 20 mg

Indications

No indication recorded.